image description

Belgian medical device CRO picks Cleveland for U.S. headquarters

MedCity News, August 29, 2011
A Belgian clinical research organization that focuses on cardiovascular medical devices has established its U.S. headquarters in Cleveland.

VasoStar’s vibrating guidewire takes aim at coronary artery blockages

MedCity News, August 3, 2011
A Cleveland-area startup is developing an electromagnetic vibrating catheter and guidewire system that could give interventional cardiologists a better means of pushing through serious coronary artery blockages called chronic total occlusions.

Jumpstart, RiverVest Venture Partners to invest $750,000 in Securus Medical Group

Securus Medical Group
Crain’s, August 1, 2011
Jumpstart Inc. and RiverVest Venture Partners have announced plans to invest a total of $750,000 in Securus Medical Group, a biomedical technology startup that moved to Cleveland from Boston in July.

Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant

Franz Medical, July 20, 2011
VasoStar develops a guidewire/catheter system for revascularization of completely occluded arteries as alternative to invasive surgical procedures.

Rainbow Medical in strategic cooperation with Cleveland Clinic

Rainbow Medical
Globes online, May 25, 2011
Rainbow Medical will offer Cleveland Clinic early-stage products and concepts for testing by the hospital’s staff.

Forest Labs to buy anti-arrhythmia drug from Blue Ash Therapeutics

Blue Ash Therapeutics
MedCity News, April 19, 2011
Cincinnati-based Blue Ash Therapeutics has reached an agreement in which Forest Laboratories will purchase the rights to an anti-arrhythmia drug the Ohio firm has been developing.

Smooth landings for Israelis in Ohio

Sensible Medical
Israel 21c, January 12, 2011
With more clinical trials by Israeli biomed firms being held in Ohio than in any other state, it’s clear that its priority to woo Israel businesses is bearing fruit.

Global Cardiovascular Innovation Center